Unlocking the benefits of the Baveno VI guidance when screening for varices: an audit of clinical practice across London.
Future Healthc J
; 9(1): 41-44, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-1776632
ABSTRACT
Background:
The Baveno VI consensus identifies patients with compensated advanced chronic liver disease (cACLD) who can safely avoid screening endoscopy. However, concordance in clinical practice with this guidance is unknown. We audited clinical practice and the provision of transient elastography (TE) aiming to identify potential cost savings and benefits.Methods:
Retrospective data collection from 12 sites across London over 6 months by reviewing oesophagogastroduodenoscopy (OGD) reports, platelet count and TE results as well as information on site-specific provision of TE.Results:
Three-hundred and fifty-one screening procedures were identified; 177 (50.43%) had a TE test performed within the preceding 12 months; 142 (80.23%) patients with a recent TE test did not meet criteria for screening OGD. TE provision varied widely between sites.Conclusion:
Improving concordance with the Baveno criteria through improved provision of TE would have benefits for patients, healthcare systems and the environment and would help to address the challenges of moving on from the COVID-19 pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Future Healthc J
Year:
2022
Document Type:
Article
Affiliation country:
Fhj.2021-0130
Similar
MEDLINE
...
LILACS
LIS